Geisinger

Nonprofit profile at a glance

EIN
232171417
IRS 990 coverage
2012–2024
Official website data refreshed
Sep 2026
Forms available
Form 990 2024, Form 990-T 2024
Location
Danville, PA, USA
Phone
5702716624
Rating
78
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Alcohol, Drug Abuse, Treatment Only

Official website

Reported finances

Revenue
$13,741,320
Expenses
$14,642,774
Assets
$6,589,727
Liabilities
$3,541,808

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

17 people listed

Executive titles in this filing

  • JAEWON RYU MD JD (PRESIDENT, DIRECTOR)
  • TERRY GILLILAND MD (PRESIDENT, DIRECTOR)
  • MICHAEL W OGDEN MPH (EXECUTIVE DIRECTOR, MARWORTH)

Highest reported compensation

  • JAEWON RYU MD JD (PRESIDENT, DIRECTOR): $14,295,895 total reported compensation
  • TERRY GILLILAND MD (PRESIDENT, DIRECTOR): $3,217,500 total reported compensation
  • KEVIN V ROBERTS MBA (EVP, CFO, TREASURER): $2,751,325 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To enhance the health and well-being of the people and communities we serve through innovative healthcare, education, and research.

What it reported doing in 2024

I. General program service information marworth, dba geisinger marworth treatment center, a 501(c)(3) not for profit corporation, owns and operates a facility for alcohol and chemical detoxification and rehabilitation. Marworth provides services without regard to the patient's ability to pay. Marworth is celebrating its 43rd year of caring for patients from Pennsylvania, New Jersey, New York and new england. More than 43,000 people have chosen marworth for treatment since 1982. Marworth provides both inpatient and outpatient care at its 91-bed facility near scranton, in waverly, Pennsylvania. The bed capacity increased from 77 to 91 in january 2006. We presently have 91 licensed beds. (1) an addiction treatment program, which provides evidence- based services to initiate and sustain recovery from substance use disorders. The program consists of three phases: (a) asam level 3.7 inpatient detox (b) asam level 3.5 high intensity inpatient rehabilitation (c) asam level 1 and 2 outpatient services (2) family treatment. A vital program component of marworth is family treatment that provides education and counseling to family members, assuring the recovery and the well-being of the entire family unit. This program is provided at no charge to the family while the patient is receiving treatment. We currently offer this service both in person and virtually. (3) non-residential services. Marworth also provides outpatient treatment services. Marworth is operated in close cooperation with educational activities of geisinger clinic and hospital facilities of geisinger community medical center and geisinger Wyoming valley medical center. (4) specialized therapies and programs. A. Recreational therapy marworth's recreational therapy program features a high ropes course, a low elements ropes course, fitness center and other experiential learning mediums. More than just exercise, rec therapy activities simulate a wide array of addiction recovery themes, such as group problem solving, learning to trust others, asking for help and confronting compulsive/impulsive behavior. B. Expressive therapy expressive therapies, such as music therapy and sand tray therapy, allow individuals in recovery to express themselves with words. The process is powerful in strengthening physical, emotional, cognitive and social needs. C. Dialectical behavioral therapy dialectical behavioral therapy (dbt) skills training teaches individuals in addiction treatment the critical coping skills of mindfulness, distress tolerance, interpersonal effectiveness and emotion regulation. D. Trauma the connection between addiction and trauma is strong. Marworth's seeking safety: trauma & ptsd support groups for trauma survivors struggling with addiction focus on coping skills, asking for help and boundaries. Picc line patients patients with peripherally inserted central catheters (picc lines) who are being treated for various infectious complications arising from their substance use can be admitted to the residential program. These patients are treated on an individual basis. Length of stay may depend on the number of days required for appropriate antibiotic therapy. If the patient has stabilized on a maintenance dose of buprenorphine, he or she will be given the option to continue this therapy or be tapered off and transitioned to an opioid blocker. These patients will undergo detoxification from all other potentially abusable substances. Buprenorphine stabilization and maintenance patients with opioid use disorder may be started and maintained on buprenorphine, the gold standard in evidence-based treatment for this disease. These patients will be maintained on the established maintenance dose of buprenorphine and will undergo detoxification from all other potentially abusable substances. Academics a. Addiction medicine fellowship the marworth addiction medicine fellowship is accredited by the accreditation council for graduate medical education (acgme) to train physicians in addict

Operating model

Revenue model
Earned-program. 97% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
  • Includes noncash contributions: Reported contributions include donated property or goods.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of voting board members are independent and expenses are high relative to revenue.

Rating breakdown

  • Financial Efficiency: 81
  • Transparency & Controls: 94
  • Accountability: 75
  • Sustainability: 13
  • Growth: 40

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 92.6%; rating input score 93
  • Program expense ratio: 87.6%; rating input score 88
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
  • Pay-setting controls: 6 of 6 controls in place; rating input score 100
    • Compensation committee: Pass
    • Independent consultant: Pass
    • Other Form 990s reviewed: Pass
    • Written employment contract: Pass
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Scored; rating input score 0

Accountability

  • Independent voting board: 57.1%; rating input score 57; 9th percentile among comparable filings
  • Governance controls: 9 of 9 controls in place; rating input score 100
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: -6.6%; rating input score 14; 14th percentile among comparable filings
  • Total-asset coverage ratio: 0.45; rating input score 13; 13th percentile among comparable filings
  • Liabilities to assets ratio: 0.54; rating input score 26; 26th percentile among comparable filings
  • Officer compensation ratio: 55.6%; rating input score 0; 0th percentile among comparable filings

Growth

  • Program expense growth: 1.3% per year; rating input score 100; 16th percentile among comparable filings
  • Revenue growth: -1% per year; rating input score 0; 6th percentile among comparable filings
  • Asset growth: -4.1% per year; rating input score 0; 3rd percentile among comparable filings

Details

  • What they do: 1 operating location identified
  • Where the money goes: 92.6% of revenue deployed · 87.6% of spending went to programs
  • Governance: 4 of 7 board members independent · 9 of 9 filing controls reported
  • Programs: 1 filed program accomplishment · $12.8M in reported program spending
  • Leadership: top reported pay $14.3M · 17 people listed · 6 of 6 pay-setting controls reported
  • Highest-paid contractors: 2 contractors listed · $269K reported
  • Consistency: 30 of 30 current checks pass
  • Schedules: 8 filed schedules · includes major donors, executive pay, and related organizations
  • Filing history: 12 filing years from 2012 to 2024
  • Contacts: How to reach this organization
  • Money network: 5 filed money-flow records
  • Related organizations: 76 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Accountability: Independent voting board scored 57/100.
  • High — Sustainability: Operating margin scored 14/100.
  • High — Growth: Revenue growth scored 0/100.
  • High — Transparency & Controls: Related-party transparency scored 0/100.
  • High — Sustainability: Total-asset coverage ratio scored 13/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Officer compensation ratio scored 0/100.
  • High — Sustainability: Liabilities to assets ratio scored 26/100.